Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Monte Rosa Therapeutics (GLUE) Treasury Shares (2023 - 2025)

Monte Rosa Therapeutics (GLUE) has 3 years of Treasury Shares data on record, last reported at $774675.0 in Q3 2025.

  • For Q3 2025, Treasury Shares rose 590.69% year-over-year to $774675.0; the TTM value through Sep 2025 reached $774675.0, up 590.69%, while the annual FY2024 figure was $112159.0, 52.58% down from the prior year.
  • Treasury Shares reached $774675.0 in Q3 2025 per GLUE's latest filing, roughly flat from $777325.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $894334.0 in Q1 2025 and bottomed at $5315.0 in Q2 2024.
  • Average Treasury Shares over 3 years is $323846.5, with a median of $236519.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: tumbled 98.19% in 2024, then surged 14525.12% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $14696.0 in 2023, then surged by 663.19% to $112159.0 in 2024, then surged by 590.69% to $774675.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $774675.0 in Q3 2025, $777325.0 in Q2 2025, and $894334.0 in Q1 2025.